Unknown

Dataset Information

0

A review to determine regulatorily and reimbursement successes of studies conducted using data from Canadian patient support programs based on the real-world evidence guidelines published by Canadian drug agency and health Canada

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC12371237 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Canadian colorectal cancer screening programs: How do they measure up using the International Agency for Research on Cancer criteria for organized screening?
| S-EPMC11317627 | biostudies-literature
Unknown The Status of Specialized Ambulatory Heart Failure Care in Canada: A Joint Canadian Heart Failure Society and Canadian Cardiovascular Society Heart Failure Guidelines Survey.
| S-EPMC7242502 | biostudies-literature
Genomics Canada C3 - Pan-Canadian coastal surface eDNA
| PRJNA1089704 | ENA
Unknown Canadian guidelines for colorectal cancer screening.
| S-EPMC3202353 | biostudies-literature
Unknown Clinical study reports published by the European Medicines Agency 2016-2018: a cross-sectional analysis.
| S-EPMC10186437 | biostudies-literature
Unknown Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies.
| S-EPMC8301545 | biostudies-literature
Unknown Abortion education in Canadian family medicine residency programs.
| S-EPMC5984743 | biostudies-literature
Unknown Developmental chromatin programs determine oncogenic competence in melanoma.
| S-EPMC9440978 | biostudies-literature
Unknown Population Genome Programs across the Middle East and North Africa: Successes, Challenges, and Future Directions.
| S-EPMC10601860 | biostudies-literature
Unknown A checklist for managed access programmes for reimbursement co-designed by Canadian patients and caregivers.
| S-EPMC6250858 | biostudies-literature